William Blair Downgrades MiNK Therapeutics (INKT) to Market Perform
Tweet Send to a Friend
(Updated - July 14, 2025 7:22 AM EDT)
William Blair analyst Matt Phipps downgraded MiNK Therapeutics (NASDAQ: INKT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William Blair analyst Matt Phipps downgraded MiNK Therapeutics (NASDAQ: INKT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
